Personal Products

According to Wedbush, Nu Skin Enterprises (NYSE: NUS) price target is raised to $48. Wedbush said that it is upgrading NUS to Outperform. “Given potential multiple expansion as expected success of major upcoming product launches should further solidify Nu Skin's reputation as a successful...

Wedbush Securities has upgraded Nu Skin Enterprises (NYSE: NUS) from Neutral to Outperform and has raised the price target from $40 to $48.

CNH Global N.V. (NYSE: CNH) +5.47 on heavy volume. NovaGold Resources Inc. (NYSE: NG) +5.45% on rising gold price. Stillwater Mining Company (NYSE: SWC) +5.80% on rising gold price. Jazz Pharmaceuticals (NASDAQ: JAZZ) +6.25% on heavy volume. Lender Processing Services (NYSE: LPS) +6.17% after...

Oppenheimer is out with its report today on American Oriental Bioengineering (NYSE: AOB), maintaining Perform. In its report, Oppenheimer writes, "AOB's 2Q11 revenue declined by 30% yoy, as the company shifted product mix to high-margin products in face of headwinds from drug price cut and high...

USANA Health Sciences, Inc. (NYSE: USNA) today announced it was named an official partner of the U.S. Ski Team, U.S. Snowboarding and U.S. Freeskiing. USANA will be providing health supplements and other nutritional products to the athletes of the U. S. Ski and Snowboard Associatio, the national...

USANA Health Sciences, Inc. (NYSE: USNA) today announced its plans to expand into France and Belgium in the first quarter of 2012. With the addition of these two markets, USANA will have operations in 18 markets worldwide. According to the World Federation of Direct Selling Associations (WFDSA),...

According to Citi, Avon Products (NYSE: AVP) didn't benefit from improved industry trends in 2010. Citi said that the US Direct Selling Association recently released its 2010 industry estimates. “The $29 billion U.S. direct selling industry delivered 4% compound annual growth between 1992 and 2010...

This is your Benzinga news summary and traders' outlook for Thursday, August 25, 2011, covering headlines from overnight and Thursday's pre-market session. Today in domestic pre-market trading, U.S equity futures are trading slightly higher. At last check, Dow futures are up about 25 points and...

Citigroup has lowered the price target on Avon Products (NYSE: AVP) from $35 to $30 and maintains its Buy rating.

Reliv International, Inc. (NASDAQ: RELV), Soy Labs LLC and the Missouri Plant Science Center today announced a new joint research and development partnership that will give Reliv greater access to the latest soy and plant biotechnology research.

USANA Health Sciences, Inc. (NYSE: USNA) today announced that it has filed two new U.S. patents on its popular liver health supplement, Hepasil DTX™. A science-based company, USANA currently holds patents for Olivol® olive extract, a unique extract that contains antioxidant polyphenols derived...

The Estée Lauder Companies Inc. (NYSE: EL) announced today that Richard W. Kunes, Executive Vice President and Chief Financial Officer, plans to retire effective on or about June 30, 2013. Mr. Kunes intends to continue to serve the Company as CFO until June 30, 2012, or such earlier time as his...

Below are the top small-cap drug related products stocks on the NYSE and the NASDAQ in terms of earnings per share. The trailing-twelve-month earnings per share at USANA Health Sciences Inc (NYSE: USNA) is $3.13. USNA's PEG ratio is 0.54. The trailing-twelve-month earnings per share at...

According to Jefferies, Estee Lauder (NYSE: EL) price target is lowered to $107. Jefferies said that the 12-month price objective is now $107, which is 23x the C2012E EPS of $4.65, a slight premium to its pre-recession average of 20.5x, with a range of 15x-27x, given what we believe could be...

Jefferies & Company has lowered the price target on Estee Lauder (NYSE: EL) from $120 to $107 and maintains its Buy rating.